Cosentyx of Novartis Gets US FDA approval in Pediatric Plaque Psoriasis
Posted on04 Jun 2021
Tagscornerstone cytokine, cosentyx, Cosentyx for plaque psoriasis, novartis, Novartis got approval for Cosentyx, Plaque psoriasis, psoriasis
Comments0
The U.S. Food and Drug Administration (FDA) has approved Novartis’ blockbuster drug Cosentyx® (secukinumab) for pediatric patients aged six years and older with moderate-to-severe plaque psoriasis.... Read More
Celgene’s Otezla (Apremilast) receives Japanese regulatory approval
Posted on24 Dec 2016
TagsApremilast, Celgene, drug regulatory body in japan, Labor and Welfare, Ministry of Health, Plaque psoriasis, psoriasis
Comments0
Brand Name: Otezla Molecule: Apremilast Developed By: Celgene Corporation Apremilast (brand name Otezla) is a medication for the treatment of certain types... Read More
FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis
The FDA has approved the biosimilar Inflectra (infliximab-dyyb) for multiple indications. Infectra is a biosimilar to Remicade (infliximab), and can be prescribed... Read More